Meredith Brown-Tuttle

Meredith Brown-Tuttle is an accomplished regulatory affairs professional with extensive experience spanning nearly two decades. Currently serving as Executive Director of Regulatory Affairs at Crinetics Pharmaceuticals since March 2025, Meredith previously held the role of Chief Regulatory Strategist at Regulatorium from March 2007 to March 2025, where responsibilities included managing IND submissions and developing regulatory strategies. Additional roles include Vice President of Regulatory Affairs at Recursion and Vice President of Regulatory & Quality at Lyric Pharmaceuticals, as well as a Board Member at the Alliance for Artificial Intelligence in Healthcare. Educational qualifications include a degree in Clinical Trials Design and Management from the University of California, Santa Cruz, and a BA in Neuroscience from San José State University.